Skip to content
Home/Companies/Healthcare/Arvelle
AR

Arvelle

Healthcare·Switzerland·Exited 2021·Held 2yr

Arvelle is a healthcare company, headquartered in Switzerland.

Entry
2019
Hold
2yr
Exit
2021
Est. EV
–

Who owns Arvelle?

Arvelle was owned by Andera Partners through BioDiscovery 5 (2017 vintage) from 2019 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 5 · 2017 · VC

Key facts

HQSwitzerland
SectorHealthcare
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from BioDiscovery 5

Other portfolio companies in the same fund.

Amolyt Pharma
Exited 2024
HealthcareFrance· 2021
to
Evommune
Exited 2025
HealthcareFrance· 2021
to
Nyxoah
Active
HealthcareBelgium· 2020
AgoMab
Exited 2026
HealthcareFrance· 2019
to
AM Pharma
Active
HealthcareNetherlands· 2019
Exciva
Active
HealthcareUS· 2019

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings